Amylyx price target raised to $28 from $19 at Baird
Upside potential remains despite near-term pullback.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential remains despite near-term pullback.
What happened, with direct paths to the underlying reporting
Baird lifts AMLX target to $28; current price $24.19; priceChangeSinceSignal -5.66.
Target: $26
Posted price: $20.18
Analyst firm: RBC Capital
Analyst: Kendall Au
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.